Evidence map›Paper›PMID 23867732›Full record

ArticlePain2013

Facial pain with localized and widespread manifestations: separate pathways of vulnerability.

Gary D Slade, Shad B Smith, Dmitri V Zaykin, Inna E Tchivileva, Dustin G Gibson, Anton Yuryev, Ilya Mazo, Eric Bair, Roger Fillingim, Richard Ohrbach and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03364075 (Genetic Variants Associated With the Occurrence of Localized Low Back Pain or Low Back Pain With Widespread Pain Symptoms, and Their Response to Treatment With Duloxetine or Propranolol), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03364075 phase2terminatednot on this mapstarted 2017, after this paper: background citation

Genetic Variants Associated With the Occurrence of Localized Low Back Pain or Low Back Pain With Widespread Pain Symptoms, and Their Response to Treatment With Duloxetine or Propranolol

TypeinterventionalSponsorMark WareRan2017 to 2018Enrolled10ConditionsLow Back PainArmsDuloxetine, Propranolol, Genotype for SNPs associated to Serotonin and COMT, Placebo Treatment
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Phenotypic Features of Central Sensitization.Journal of applied biobehavioral research · 2018
    Article
  8. Article
  9. Epiregulin and EGFR interactions are involved in pain processing.The Journal of clinical investigation · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. MicroRNA expression profiles differentiate chronic pain condition subtypes.Translational research : the journal of laboratory and clinical medicine · 2015
    Article
  14. Unraveling the challenge of head and face pain.The Journal of manual & manipulative therapy · 2014
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gary D SladeRegional Center for Neurosensory Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Department of Dental Ecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA Ariadne Diagnostics LLC, Rockville, MD, USA Department of Community Dentistry & Behavioral Science, University of Florida, Gainesville, FL, USA Department of Oral Diagnostic Sciences, University at Buffalo, Buffalo, NY, USA University of Maryland School of Dentistry, Baltimore, MD, USA.
Shad B Smith
Dmitri V Zaykin
Inna E Tchivileva
Dustin G Gibson
Anton Yuryev
Ilya Mazo
Eric Bair
Roger Fillingim
Richard Ohrbach
Joel Greenspan
William Maixner
Luda Diatchenko

Funding

Risk Factors for Onset and Persistence of TMDU01DE017018 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DIATCHENKO, LUDA, FILLINGIM, ROGER B · 2005 to 2016
$35.9M
Vulvar Vestibulitis syndrome (VVS)P01NS045685 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NACKLEY, ANDREA G · 2004 to 2014
$12.5M
Statistical, population genetics and genetic epidemiologyZIAES101866 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ZAYKIN, DMITRI V · 2009 to 2021
$5.8M
COMT &betaAR Polymorphism &Development of Painful TMDR01DE016558 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DIATCHENKO, LUDA · 2005 to 2009
$1.7M
Biomedical Researcher Development Program in TMJD and Orofacial PainK12DE022793 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIM, PEI FENG, MAIXNER, WILLIAM · 2012 to 2016
$1.3M
Intramural NIH HHSNIDCR NIH HHS K12 DE022793NIDCR NIH HHS R01 DE016558NIDCR NIH HHS R01-DE16558NIDCR NIH HHS U01 DE017018NIDCR NIH HHS UO1-DE017018NINDS NIH HHS P01 NS045685
6 · The paper itself

Abstract

Human association studies of common genetic polymorphisms have identified many loci that are associated with risk of complex diseases, although individual loci typically have small effects. However, by envisaging genetic associations in terms of cellular pathways, rather than any specific polymorphism, combined effects of many biologically relevant alleles can be detected. The effects are likely to be most apparent in investigations of phenotypically homogenous subtypes of complex diseases. We report findings from a case-control, genetic association study of relationships between 2925 single nucleotide polymorphisms (SNPs) and 2 subtypes of a commonly occurring chronic facial pain condition, temporomandibular disorder (TMD): 1) localized TMD and 2) TMD with widespread pain. When compared to healthy controls, cases with localized TMD differed in allelic frequency of SNPs that mapped to a serotonergic receptor pathway (P=0.0012), while cases of TMD with widespread pain differed in allelic frequency of SNPs that mapped to a T-cell receptor pathway (P=0.0014). A risk index representing combined effects of 6 SNPs from the serotonergic pathway was associated with greater odds of localized TMD (odds ratio 2.7, P=1.3 E-09), and the result was reproduced in a replication case-control cohort study of 639 people (odds ratio 1.6, P=0.014). A risk index representing combined effects of 8 SNPs from the T-cell receptor pathway was associated with greater odds of TMD with widespread pain (P=1.9 E-08), although the result was not significant in the replication cohort. These findings illustrate potential for clinical classification of chronic pain based on distinct molecular profiles and genetic background.

Indexed as

AdolescentAdultCase-Control StudiesCohort StudiesDNAFacial PainFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedModels, GeneticOdds RatioPhenotypePolymorphism, Single NucleotideDNAReceptors, Antigen, T-CellSerotoninCase-control studyHuman geneticsSerotonergic receptorTemporomandibular disorder

Identifiers

PMID23867732
PMCPMC3808468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.